Kim Hanjoon Alex 4
4 · STANDARD BIOTOOLS INC. · Filed Apr 5, 2024
Insider Transaction Report
Form 4
Kim Hanjoon Alex
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-04-04+70,183→ 140,366 total - Award
Common Stock
2024-04-05+70,702→ 211,068 total - Exercise/Conversion
Restricted Stock Units
2024-04-04−70,183→ 140,366 total→ Common Stock (70,183 underlying)
Footnotes (3)
- [F1]On April 11, 2023, the Reporting Person was granted a target amount of 77,185 performance-based restricted stock units ("RSUs") under the Issuer's 2011 Equity Incentive Plan, as amended. Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 70,702 RSUs as of March 31, 2024.
- [F2]Each RSU represents the contingent right to receive one share of the Issuer's common stock.
- [F3]On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.